Re: 'Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: a comparative analysis using three-dimensional mapping' (Cardiovasc Res 2000;45:310-320) 
Although the technique of three-dimensional mapping shown to be very common in both ischemic [5] [6] [7] and obviously does not provide direct evidence as to whether nonischemic arrhythmias [8, 9] . ET-1-induced ventricular arrhythmias are purely due to ischemia or to a combination of direct electrophysiologic As far as the potential mechanism underlying the effects and ischemia, we still believe that a number of growing prevalence of right ventricular foci with increasaspects argue against the hypothesis that ET-1 related ing duration of ET-1 infusion is concerned, we believe that arrhythmogenesis is exclusively based on ischemia: recent experimental work supports the hypothesis of a systemic recirculation of ET-1. Although the elimination 1. The fact that conduction and refractory properties kinetics of ET-1 are still poorly understood, Parker et al. remained entirely unaffected by ET-1.
[10] could demonstrate in healthy individuals that intraven-2. The difference in the mechanism responsible for the ously applied ET-1 has a much longer terminal half life maintenance of observed arrhythmias (purely focal vs.
than previously reported. Furthermore, as shown exfocal and reentrant).
perimentally in rats, plasma endothelin concentration after 3. The occurrence of severe arrhythmias in the presence of bolus administration of endothelin is significantly proa minor degree of coronary blood flow reduction (24-longed by bilateral nephrectomy [11] . These data clearly 32%), as indicated by previous studies using exactly the indicate that the pulmonary elimination of endothelin is same dose of ET-1 [1,2].
incomplete and, thus, the endothelin plasma level might 4. The observation that bradycardia enhances the arwell increase with continuous i.v. infusion as applied in rhythmogenic effect of ET-1 [3] , whereas induction our study, although this has not been systematically rates with programmed ventricular stimulation are low studied yet.
We are convinced that our study indirectly supports the 5. The fact that previous experimental studies failed to hypothesis derived from earlier experimental work that, demonstrate a correlation between the severity of apart from its vasoconstrictive properties, ET-1 exerts ischemia and the severity of ET-1-induced ventricular primary arrhythmogenic effects. However, further exarrhythmias [4] . The predominance of focal arrhythmias perimental data are required to directly prove this hypothoriginating from the subendocardium in both the ET-1 esis. and the ligation group does not allow the conclusion that ischemia is the mechanism underlying both interventions, because this type of arrhythmia has been References 
